144 related articles for article (PubMed ID: 6335692)
1. Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.
Javitch JA; Snyder SH
Eur J Pharmacol; 1984 Nov; 106(2):455-6. PubMed ID: 6335692
[No Abstract] [Full Text] [Related]
2. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
Sershen H; Mason MF; Debler EA; Lajtha A
Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
[TBL] [Abstract][Full Text] [Related]
4. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
Chiba K; Trevor AJ; Castagnoli N
Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
Shen RS; Abell CW; Gessner W; Brossi A
FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
Hirata Y; Nagatsu T
Tanpakushitsu Kakusan Koso; 1986 Apr; 31(5):398-409. PubMed ID: 3520683
[No Abstract] [Full Text] [Related]
7. Potent neurotoxic fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs as potential probes in models of Parkinson disease.
Riachi NJ; Arora PK; Sayre LM; Harik SI
J Neurochem; 1988 Apr; 50(4):1319-21. PubMed ID: 3258018
[TBL] [Abstract][Full Text] [Related]
8. Pargyline prevents MPTP-induced parkinsonism in primates.
Langston JW; Irwin I; Langston EB; Forno LS
Science; 1984 Sep; 225(4669):1480-2. PubMed ID: 6332378
[TBL] [Abstract][Full Text] [Related]
9. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
Heikkila RE; Sieber BA; Manzino L; Sonsalla PK
Mol Chem Neuropathol; 1989 Jun; 10(3):171-83. PubMed ID: 2669769
[No Abstract] [Full Text] [Related]
10. N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria.
Frei B; Richter C
FEBS Lett; 1986 Mar; 198(1):99-102. PubMed ID: 3082673
[TBL] [Abstract][Full Text] [Related]
11. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
Nature; 1987 May 28-Jun 3; 327(6120):324-6. PubMed ID: 2884568
[TBL] [Abstract][Full Text] [Related]
12. Further insight into the mode of action of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Gessner W; Brossi A; Shen RS; Abell CW
FEBS Lett; 1985 Apr; 183(2):345-8. PubMed ID: 3872811
[TBL] [Abstract][Full Text] [Related]
13. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of recovery in MPTP-induced parkinsonism.
Sandyk R
Neuroscience; 1988 Nov; 27(2):727-9. PubMed ID: 3146035
[No Abstract] [Full Text] [Related]
15. Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.
Melamed E; Pikarski E; Goldberg A; Rosenthal J; Uzzan A; Conforti N
Brain Res; 1986 Dec; 399(1):178-80. PubMed ID: 3492237
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse.
Sundström E; Jonsson G
Eur J Pharmacol; 1985 Apr; 110(3):293-9. PubMed ID: 3874083
[TBL] [Abstract][Full Text] [Related]
17. MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture.
Snyder SH; D'Amato RJ
Neurology; 1986 Feb; 36(2):250-8. PubMed ID: 3080696
[TBL] [Abstract][Full Text] [Related]
18. The dopamine neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset.
Gibb WR; Lees AJ; Jenner P; Marsden CD
Neurosci Lett; 1986 Mar; 65(1):79-83. PubMed ID: 3486388
[TBL] [Abstract][Full Text] [Related]
19. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
[TBL] [Abstract][Full Text] [Related]
20. Dopamine in the extrapyramidal motor function. A study based upon the MPTP-induced primate model of parkinsonism.
Chiueh CC
Ann N Y Acad Sci; 1988; 515():226-38. PubMed ID: 3259118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
